ClinicalTrials.gg
CompletedNCT05131503Updated Jul 27, 2022

Evaluation of The Fear of Childbirth

An observational study in Fear of Childbirth, sponsored by Ankara City Hospital Bilkent. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-27.

Sponsored by Ankara City Hospital Bilkent · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
500
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

Most pregnant women have fear of labor. The reasons of fear of labor are different according to women. The investigators will examine the relationship between the descriptive features and level of fear of labor of pregnant women by using the Oxford worries about labour scale

Read the detailed description

The investigators will give a survey to pregnant women who go to the antenatal polyclinic. The survey is consisted by researchers. The survey has a few questions about pregnant women's descriptive features. Next the investigators will evaluate the level of fear of labor of pregnant women. After the investigators will analyze the relationship between pregnant women's fear and their descriptive features.

02

Conditions studied

  • Fear of Childbirth

Keywords

  • fear
  • Parturition
  • midwifery
  • Pregnant Women
03

In context

Lead sponsor

Ankara City Hospital Bilkent is the lead sponsor of 439 studies on the registry; 110 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

they are healthy pregnant women who are 18-35 years old. they do not have any obstetrical complications. they go to the antenatal polyclinic.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • all of volunteers and pregnant women who are 18-35 years old.

Exclusion criteria

Exclusion Criteria:

  • the pregnant women have any obstetrical complications.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
500 participants (actual)
Patient registry
No

Interventions

  • OtherSurvey Research

    Non-applicable. There is no intervention. This study is descriptive research.

06

What researchers measure

Primary outcomes

  1. The Oxford Worries About Labour Scale

    This scale measures the level of fear of childbirth. The scale has ten questions which has four answers as Likert Scale. Also the scale has 40-100 points. As the point decreases the fear score increases.

    Time frame: approximately 30 minutes, waiting in the antenatal polyclinic.

07

Study locations

1 site
  • Ankara City Hospital- Maternity Hospital
    Ankara, Çankaya, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2021 to primary completion in Jan 2022, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2021
First posted
Nov 23, 2021
StartActual
Sep 15, 2021
Primary completionActual
Jan 15, 2022
CompletionActual
Mar 15, 2022
Last update
Jul 27, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05131503
Responsible party
Nükhet Kaçar (Principal Investigator, Ankara City Hospital Bilkent) — Principal investigator
First posted
Nov 23, 2021
Start date
Sep 15, 2021
Primary completion
Jan 15, 2022
Completion
Mar 15, 2022
Last update
Jul 27, 2022

Study contacts

Nükhet Kaçar, MSc.
principal investigator · Ankara City Hospital- Maternity Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion